Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
12.78
+0.28 (2.24%)
At close: Jun 6, 2025, 4:00 PM
13.12
+0.34 (2.66%)
After-hours: Jun 6, 2025, 6:56 PM EDT
Nurix Therapeutics Stock Forecast
Stock Price Forecast
According to 17 professional analysts, the 12-month price target for Nurix Therapeutics stock ranges from a low of $16 to a high of $41. The average analyst price target of $30.71 forecasts a 140.30% increase in the stock price over the next year.
Price Target: $30.71 (+140.30%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 29, 2025.
Analyst Ratings
The average analyst rating for Nurix Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 9 | 9 | 9 | 8 | 8 | 8 |
| Hold | 1 | 1 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 17 | 17 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $27 | Strong Buy | Reiterates | $27 | +111.27% | Apr 29, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $32 → $25 | Buy | Maintains | $32 → $25 | +95.62% | Apr 9, 2025 |
| Stifel | Stifel | Strong Buy Maintains $36 → $35 | Strong Buy | Maintains | $36 → $35 | +173.87% | Apr 9, 2025 |
| Needham | Needham | Strong Buy Maintains $28 → $27 | Strong Buy | Maintains | $28 → $27 | +111.27% | Apr 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +181.69% | Apr 2, 2025 |
Financial Forecast
Revenue This Year
62.97M
from 54.55M
Increased by 15.43%
Revenue Next Year
59.69M
from 62.97M
Decreased by -5.21%
EPS This Year
-3.09
from -2.88
EPS Next Year
-3.32
from -3.09
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 93.7M | 99.8M | 214.5M | ||
| Avg | 63.0M | 59.7M | 83.4M | ||
| Low | 18.1M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 71.8% | 58.4% | 259.4% | ||
| Avg | 15.4% | -5.2% | 39.7% | ||
| Low | -66.8% | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.14 | -1.70 | -1.63 | ||
| Avg | -3.09 | -3.32 | -3.14 | ||
| Low | -3.49 | -4.51 | -4.07 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.